Discover medical breakthroughs and policy insights to stay informed on healthcare trends.
Healthcare
Assort Health, a startup using artificial intelligence to automate patient communication for specialty healthcare practices, has raised about $50 million in a Series B round at a valuation of $750 million, according to three people familiar with the deal. The financing, led by Lightspeed Venture Partners, comes just four months
Pharmaceutical
AbbVie has agreed to acquire an experimental depression treatment from Gilgamesh Pharmaceuticals in a deal worth up to $1.2 billion, marking a significant step in the drugmaker’s push into next-generation psychiatric medicines. Under the agreement, AbbVie will acquire Gilgamesh’s lead asset, bretisilocin (GM-2505), an investigational therapy for
Health
The Food and Drug Administration (FDA) has approved the first-ever glucose monitoring system designed specifically for weight loss, developed by health-tech startup Signos. The decision, announced Wednesday, creates a new pathway for Americans seeking to manage their weight outside of traditional treatments like medication or surgery. A New Option Beyond
Pharmaceutical
Varda Space is pushing the boundaries of pharmaceutical production by taking the process out of Earth’s gravity well and into orbit. The company announced a $187 million Series C funding round on Thursday to accelerate its mission of using space as a unique environment for drug manufacturing. With gravity
Healthcare
In a striking show of investor confidence, AI health tech startup Abridge has doubled its valuation to $5.3 billion just four months after its previous funding round. The Pittsburgh-based company has secured a $300 million Series E round, led by Andreessen Horowitz with continued backing from Khosla Ventures, according
Health
Digital health startup Sword Health has secured a fresh $40 million in funding at a $4 billion valuation, marking a 33% increase from its $3 billion valuation just a year ago. The round was led by returning backer General Catalyst, with participation from Khosla Ventures, Comcast Ventures, and several other
Healthcare
In a bold move to solidify its international presence, Hims & Hers Health announced Tuesday it will acquire Zava, a prominent European telehealth platform. The acquisition marks a pivotal step in the U.S.-based company's strategy to expand beyond domestic borders and tap into growing demand for
Biotechnology
Samsung’s venture capital arm is preparing to invest in California-based medical device startup Exo, as part of a funding round that could reach $100 million. The round is reportedly being led by Sands Capital, Bold Capital, and Qubit Health Capital. Notably, Qubit Health’s chairman, former Medtronic CEO Omar
Biotechnology
Pharmaceutical giant Regeneron announced Monday that it will acquire genetic testing company 23andMe for $256 million, following a court-supervised bankruptcy auction. The deal, if approved, will grant Regeneron ownership of 23andMe’s genomics service and a massive trove of personal and genetic data from roughly 15 million customers. The acquisition
Biotechnology
Biotech startup NewLimit, which is focused on extending healthy human lifespan through cellular reprogramming, has raised a $130 million Series B round led by Kleiner Perkins. The round also included new investors Nat Friedman, Daniel Gross, and Khosla Ventures, along with returning backers like Founders Fund, Dimension Capital, Elad Gil,
Pharmaceutical
Merck is making a $1 billion bet on American manufacturing with plans to build a major production facility in Wilmington, Delaware. The 470,000-square-foot site will be dedicated to producing Keytruda, Merck’s blockbuster cancer immunotherapy drug, for U.S. patients. This marks the company’s first domestic site devoted
Pharmaceutical
Swiss pharmaceutical giant Roche announced a massive $50 billion investment in the United States over the next five years, reinforcing its commitment to the American market amid rising concerns about looming White House tariffs on imported pharmaceutical goods. The investment will generate over 12,000 jobs, with 1,000 directly